Switch theme
Sign up to access all valuation multiples
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
1987
1.6K+
LTM Revenue $806M
LTM EBITDA $73.5M
$575M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Orthofix Medical has a last 12-month revenue (LTM) of $806M and a last 12-month EBITDA of $73.5M.
In the most recent fiscal year, Orthofix Medical achieved revenue of $799M and an EBITDA of -$18.2M.
Orthofix Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Orthofix Medical valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $806M | XXX | $799M | XXX | XXX | XXX |
| Gross Profit | $555M | XXX | $546M | XXX | XXX | XXX |
| Gross Margin | 69% | XXX | 68% | XXX | XXX | XXX |
| EBITDA | $73.5M | XXX | -$18.2M | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | -2% | XXX | XXX | XXX |
| EBIT | -$74.4M | XXX | -$77.7M | XXX | XXX | XXX |
| EBIT Margin | -9% | XXX | -10% | XXX | XXX | XXX |
| Net Profit | -$21.5M | XXX | -$126M | XXX | XXX | XXX |
| Net Margin | -3% | XXX | -16% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $73.8M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Orthofix Medical's stock price is $11.
Orthofix Medical has current market cap of $440M, and EV of $575M.
See Orthofix Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $575M | $440M | XXX | XXX | XXX | XXX | $-2.83 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Orthofix Medical has market cap of $440M and EV of $575M.
Orthofix Medical's trades at 0.7x EV/Revenue multiple, and -31.5x EV/EBITDA.
Equity research analysts estimate Orthofix Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Orthofix Medical has a P/E ratio of -20.4x.
See valuation multiples for Orthofix Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $440M | XXX | $440M | XXX | XXX | XXX |
| EV (current) | $575M | XXX | $575M | XXX | XXX | XXX |
| EV/Revenue | 0.7x | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | 7.8x | XXX | -31.5x | XXX | XXX | XXX |
| EV/EBIT | -7.7x | XXX | -7.4x | XXX | XXX | XXX |
| EV/Gross Profit | 1.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | -20.4x | XXX | -3.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -63.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialOrthofix Medical's last 12 month revenue growth is 3%
Orthofix Medical's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.4M for the same period.
Orthofix Medical's rule of 40 is -7% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Orthofix Medical's rule of X is 18% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Orthofix Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | -2% | XXX | XXX | XXX |
| EBITDA Growth | 15% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -7% | XXX | 1% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 18% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 9% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 78% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Orthofix Medical acquired XXX companies to date.
Last acquisition by Orthofix Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Orthofix Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Orthofix Medical founded? | Orthofix Medical was founded in 1987. |
| Where is Orthofix Medical headquartered? | Orthofix Medical is headquartered in United States of America. |
| How many employees does Orthofix Medical have? | As of today, Orthofix Medical has 1.6K+ employees. |
| Who is the CEO of Orthofix Medical? | Orthofix Medical's CEO is Mr. Massimo Calafiore. |
| Is Orthofix Medical publicy listed? | Yes, Orthofix Medical is a public company listed on NAS. |
| What is the stock symbol of Orthofix Medical? | Orthofix Medical trades under OFIX ticker. |
| When did Orthofix Medical go public? | Orthofix Medical went public in 1992. |
| Who are competitors of Orthofix Medical? | Similar companies to Orthofix Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Orthofix Medical? | Orthofix Medical's current market cap is $440M |
| What is the current revenue of Orthofix Medical? | Orthofix Medical's last 12 months revenue is $806M. |
| What is the current revenue growth of Orthofix Medical? | Orthofix Medical revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Orthofix Medical? | Current revenue multiple of Orthofix Medical is 0.7x. |
| Is Orthofix Medical profitable? | Yes, Orthofix Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Orthofix Medical? | Orthofix Medical's last 12 months EBITDA is $73.5M. |
| What is Orthofix Medical's EBITDA margin? | Orthofix Medical's last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of Orthofix Medical? | Current EBITDA multiple of Orthofix Medical is 7.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
